Please login to the form below

Not currently logged in
Email:
Password:

Senior changes at EMA

New head of IT and chair of committee for advanced therapies
EMA Dina Tsiambaou

The European Medicines Agency (EMA) has announced changes in leadership for both its IT division and its Committee for Advanced Therapies (CAT).

Dina Tsiambaou (pictured) joins the Agency, which regulates medicines in the EU, as head of the IT development department. She was previously a senior manager in IT at management consultancy Accenture.

In this role she gained experience working in a number of regions, including China, Mauritius, Thailand, Singapore, Turkey, the US, Germany and Ireland.

The EMA's other new appointment was that of Dr Paula Salmikangas as chair of the CAT, the EMA committee responsible for assessing the quality, safety and efficacy of advanced-therapy medicinal products.

She was previously vice-chair of the committee and succeeds Christian Schneider, who had chaired the CAT since its creation in 2009.

In addition to her EMA role, Dr Salmikangas is a senior research at the Finnish Medicines Agency.

18th February 2014

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of animators and science experts creating photo real life-science animation content for the healthcare and...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics